Approximately 40 million people are infected with HIV and the major limitation in HIV drug therapy is loss of effectiveness due to HIV acquiring resistance mutations. Here, we present HIVAtlas, a new rational-based strategy for designing patient therapy that does not require genome sequencing of the viral isolates, rather uses vast amounts of existing data to select antiretroviral therapy base don geographic location and treatment status. HIVAtlas should help design of more effective HIV therapies, minimize global drug resistance to antiretrovirals, decrease the mortality of infected patients, and reducing the economic cost of treating patients. HIVAtlas was built by Sandeep Deverasetty, with contributions from David Sargeant, Dr. Christy Strong, Viraj Rathnayake, Dorthea Maza, and Sean Tuggle.

PLEASE CITE USE OF HIVATLAS WITH THIS PAPER:
manuscript is submitted